Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that is in Phase 3 clinical trials for the adjunctive or monotherapy treatment of major depressive disorder in adults. The company was founded in 2004 and is headquartered in Coral Gables, Florida.

Explore Relmada Therapeutics, Inc. (RLMD) trends on wallstreetbets, highlighting its potential as a next meme stock. Check if RLMD ranks among the best meme stocks today, signaling its status as a top meme stock to watch. Also, review any recent trades of RLMD by notable politicians, like Nancy Pelosi, to gauge its prominence in the meme stock conversation.

Relmada Therapeutics, Inc.

💎🤲 Meme Status

🚀 Quote

🏛️ Trades by Politicians